BML, Inc.
BML, Inc.
Share · JP3799700004 (XTKS)
Overview
No Price
Closing Price XTKS 31.10.2025: 3.630,00 JPY
31.10.2025 05:43
Current Prices from BML, Inc.
ExchangeTickerCurrencyLast TradePriceDaily Change
XTKS: Tokyo
Tokyo
4694.T
JPY
31.10.2025 05:43
3.630,00 JPY
75,00 JPY
+2,11 %
Share Float & Liquidity
Free Float 42,99 %
Shares Float 16,77 M
Shares Outstanding 39,01 M
Invested Funds

The following funds have invested in BML, Inc.:

Fund
iShares Core MSCI Japan IMI UCITS ETF EUR Hedged (Acc)
Vol. in million
12,63
Percentage (%)
0,02 %
Fund
iShares Core MSCI Japan IMI UCITS ETF USD (Dist)
Vol. in million
30,93
Percentage (%)
0,02 %
Company Profile for BML, Inc. Share
BML, Inc. provides laboratory testing and related services in Japan. The company offers general laboratory tests, including biochemical and hematologic examinations; special laboratory tests, such as RIA, cellular, immunological, and DNA analysis; microbiological tests for medical and pharmaceutical societies and organizations; and laboratory tests in tumorology, infectious disease, diabetes, hypertension, allergy, and genetic studies. It also develops Frontier and Symphony automation systems, which automate pre-processing procedures from sorting to dispensing, and subsequent test procedures; and provides electronic medical charts for networking medical information, as well as offers preventive medicine services. In addition, the company provides food sanitation control and food processing services comprising contract services for microorganism testing of raw materials, and prepared and processed foods; environmental hygiene testing of food processing facilities and kitchens; and microorganism testing services, as well as assesses genetically modified organisms. Further, it provides drinking water and waste water tests; work sanitation management services, such as measurement of ethylene oxide gas, formaldehyde, organic solvents, and dust; environmental monitoring services, including measurement of indoor contaminants and other indoor environmental variables; and biological dioxin monitoring services. Additionally, the company offers analysis services for residual agricultural chemicals; dental test services for dental caries and periodontal diseases; consulting services for the approval of pharmaceuticals; investigative analysis services to pharmaceutical manufacturers; and gene expression analysis and testing for genes that cause susceptibility to infectious diseases. BML, Inc. was founded in 1955 and is headquartered in Tokyo, Japan.
Get up to date insights from finAgent about BML, Inc.

Company Data

Name BML, Inc.
Company BML, Inc.
Website https://www.bml.co.jp
Primary Exchange XTKS Tokyo
ISIN JP3799700004
Asset Class Share
Sector Healthcare
Industry Medical - Diagnostics & Research
CEO Kensuke Kondo
Market Capitalization 143 Mrd.
Country Japan
Currency JPY
Employees 4,5 T
Address 5-21-3 Sendagaya, Tokyo
IPO Date 2001-04-25
Dividends from 'BML, Inc.'
Ex-Date Dividend per Share
29.09.2025 60,00 JPY

Ticker Symbols

Name Symbol
Tokyo 4694.T
More Shares
Investors who hold BML, Inc. also have the following shares in their portfolio:
INTERNATIONAL FINANCE CORPORATION CALL ZRO CPN NTS 19/09/46
INTERNATIONAL FINANCE CORPORATION CALL ZRO CPN NTS 19/09/46 Bond
NEXSTAR MEDIA GROUP INC - CLASS A
NEXSTAR MEDIA GROUP INC - CLASS A Share
The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Imprint Data Protection Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025